{
    "id": 13884,
    "fullName": "FANCA del",
    "impact": "deletion",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "FANCA del indicates a deletion of the FANCA gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2175,
        "geneSymbol": "FANCA",
        "terms": [
            "FANCA",
            "FA",
            "FA-H",
            "FA1",
            "FAA",
            "FACA",
            "FAH",
            "FANCH"
        ]
    },
    "variant": "del",
    "createDate": "11/14/2015",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3781,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II clinical trial, a patient with a metastatic, castration-resistant prostate cancer harboring deletions in BRCA1 and FANCA responded to Lynparza (olaparib) as demonstrated by a reduction in circulating tumor cells (PMID: 26510020).",
            "molecularProfile": {
                "id": 14075,
                "profileName": "BRCA1 del FANCA del"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3921,
                    "pubMedId": 26510020,
                    "title": "DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26510020"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 14075,
            "profileName": "BRCA1 del FANCA del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 14076,
            "profileName": "FANCA del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}